Pharmaceutical companies have been working for years on leveraging their clinical research data in more efficient ways, but other sectors of the research industry hav...

In this paper, Chris Hamilton, Chief Commercial Officer at CROS NT, analyses how it is important to delve into the challenges when trying to achieve 'sustained' quali...

In this paper, Laure Lam Hung PhD, Project Manager and Clinical Research Associate at CIDP and Dr Tarkeswarnath Bachoo MBBS, MD (Paediatrics), Consultant Paediatricia...

The US Food and Drug Administration (FDA) allows for some flexibility related to changes in clinical trial protocols—for example, with adaptive trials. However, certa...

Immunostimulating interstitial laser thermotherapy (imILT) is a treatment protocol for solid tumours developed to destroy the tumour at the treatment site while simul...

In industry-sponsored clinical trials, as the sponsors are for-profit companies, contract negotiations with the trial sites can be difficult and complex. The smooth m...

More than six years have passed since the federal law ‘On Circulation of Medicines’ came into effect, replacing the law ‘On Medicines’. The adoption of the new legisl...

Clinical research is underdeveloped in Brazil, although the country has the requisite expertise and infrastructure. Luis Magalhaes and Le Vin Chin of Clinerion Ltd ex...

In this piece, Jennifer Goldsmith, Senior Vice President of Veeva Vault Strategy, illustrates how an increasingly complex clinical trial landscape is driving the life...

For the second part of his series on respiratory drug development, Robert Lins, Respiratory Project Director at SGS, focuses on clinical trial strategy and study desi...